Will the pharmaceutical sector have a challenging 2019?

2019 Stocks increase
From Sweta Killa: The Q4 earnings season has commenced and Johnson & Johnson (JNJ - Free Report) was the first drug company to report on Jan 22, before the opening bell. The world's biggest maker of health care products continued its long streak of earnings beat and outpaced the estimate on the revenue front. However, it offered a downbeat outlook for 2019.
NYSE:IHE January 24, 2019 5:19pm

IHE Posted The Biggest Loss Of All ETFs Today, Down 1%

Image of multicolor pills in blister pack
The iShares Dow Jones US Pharmaceuticals Index Fund (IHE) underperformed all other non-leveraged, non-inverse exchange traded products in the U.S. today on a percentage basis, producing a -0.98% one-day return and trailing the wider markets by a total of 1.35 percentage points.
NYSE:IHE January 20, 2017 6:05pm

Women Want Big Boobs In Venezuela And There Are Not Enough Breast Implants To Go Around [Dow Chemical Co(NYSE:DOW), Allergan, Inc.(NYSE:AGN), InMed Pharmaceuticals Inc(CVE:MSC.H)]

implantsWe’ve had nothing but serious Slap in the Face Awards for a while, so here’s a funny one. It goes out to Venezuela this week for its attempts to control just about everything about its economy. But, especially how much its citizens spend outside the
NYSE:IHE December 17, 2014 1:23pm

ETFs To Watch On Solid Pharma Earnings [Market Vectors Pharmaceutical ETF, iShares Dow Jones US Pharm Indx (ETF)]

healthcare3The healthcare space has emerged relatively unscathed from the biotech meltdown seen early in the year and is clearly outperforming the broad market. This is primarily thanks to strong performances by both biotech and pharma companies
NYSE:IHE October 31, 2014 3:32pm

A Beaten-Up Pharma With a Big Upside [The Medicines Company(NASDAQ:MDCO), Pfizer Inc.(NYSE:PFE), Merck & Co., Inc.(NYSE:MRK)]

biotechnologyThe Medicines Company(NASDAQ:MDCO) has had a really tough first half of 2014, and the stock price shows it. When one of its drugs did not receive approval from regulators and a court decision concerning one of its drugs going generic went against the company, the stock dropped
NYSE:IHE August 19, 2014 10:15am

ETFs To Watch On Strong Earnings From Pharma Companies [Pfizer Inc., Merck & Co., Inc., Eli Lilly and Co]

healthcare1The pharma space has been seeing smooth trading thanks to encouraging industry trends such as development of new drugs, the rising wave of mergers and acquisitions, increased need for medical services, expansion into emerging markets
NYSE:IHE July 30, 2014 5:10pm

Hepatitis C and Merck [Merck & Co., Inc., Gilead Sciences, Inc.]

drugsHepatitis C news is all over the headlines. That’s because the Hep C market is huge - $100 billion huge. And while Gilead Sciences, Inc.(NASDAQ:GILD) has been grabbing all the headlines in that area, Merck & Co., Inc.(NYSE:MRK) is right on
NYSE:FDL May 6, 2014 2:49pm

Healthcare ETFs In Focus On Johnson & Johnson Earnings [Health Care SPDR (ETF)]

healthcare2The healthcare space has seen rough trading this year due to a biotech sell-off as investors are pulling out capital from high growth and high beta stocks.
NYSE:IHE April 17, 2014 2:38pm

Top Pharmaceutical ETFs To Consider [Biogen Idec Inc, SPDR S&P Pharmaceuticals (ETF), Health Care SPDR (ETF)]

healthcare1After the incredible surge in 2013, the healthcare sector is no doubt crushing the overall market this year too. This is largely thanks to the bullish trend in both the pharma and biotech segments
NYSE:IHE March 16, 2014 4:04pm

Healthcare ETFs To Watch On Johnson & Johnson Report [Health Care SPDR (ETF)]

healthcare1Healthcare space is greatly befitting from the current favorable industry trends and robust performances by major drug companies in both pharma and biotech segments. This trend is further confirmed by the healthcare giant Johnson & Johnson’s (NYSE:JNJ) 
NYSE:IHE January 27, 2014 4:57pm

Quick Investor Guide To Pharmaceutical ETFs

healthcare-etfsWith the year coming to an end, the worst of the patent cliff faced by the pharmaceutical sector in recent times is over. Although genericization will continue, the major patent expiries are over and done with.
NYSE:IHE December 26, 2013 2:09pm

3 Pharmaceutical ETFs Leading The Healthcare Sector

healthcare1The pharmaceutical industry has been performing remarkably well this year after emerging relatively unscathed from one of the biggest patent cliffs in recent times.
NYSE:IHE November 26, 2013 12:11am

Why Investors Should Consider Pharmaceutical ETFs

healthcare-etfsThe healthcare space, no doubt, is one of the leading sectors this year courtesy of the incredible performances by major drug companies in both pharmaceutical and biotechnology industries. While the biotech sector includes the fastest growing
NYSE:IHE August 26, 2013 12:19pm

Investor Guide To Four Pharmaceutical ETFs

healthcare3The pharmaceutical industry has been showing signs of recovery from one of the biggest patent cliffs in recent times. Although genericization will continue, the major patent expiries are over and done with. Focus in the pharma sector is now shifting
NYSE:IHE August 12, 2013 4:27pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories